Corcept Therapeutics Incorporated (CORT)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 675,040 | 482,375 | 401,858 | 365,978 | 353,874 |
| Total assets | US$ in thousands | 840,553 | 621,517 | 583,430 | 423,756 | 571,731 |
| Total asset turnover | 0.80 | 0.78 | 0.69 | 0.86 | 0.62 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $675,040K ÷ $840,553K
= 0.80
Corcept Therapeutics Incorporated's total asset turnover has shown some fluctuations over the past five years. The ratio increased from 0.62 in December 2020 to 0.86 in December 2021, which indicates an improvement in the company's efficiency in generating sales from its total assets. However, in the following years, the total asset turnover slightly decreased to 0.69 in December 2022, then increased to 0.78 in December 2023, and remained relatively stable at 0.80 in December 2024.
Overall, the average total asset turnover for the period under review stands at approximately 0.75. This ratio suggests that for every dollar of assets Corcept Therapeutics holds, the company generates $0.75 in sales revenue. It is important to further investigate the reasons behind the fluctuations in total asset turnover to assess the company's asset utilization efficiency and potential operational improvements.
Peer comparison
Dec 31, 2024